"Clinically advanced, evidence-based cancer care."

During the past decade, Adirondack Cancer Care - Glens Falls conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 18 clinical trials were completed, i.e. on average, 900% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Adirondack Cancer Care - Glens Falls" #1 sponsor was "National Cancer Institute (NCI)" with 13 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "NSABP Foundation Inc" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Adirondack Cancer Care - Glens Falls" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 10 trials as a collaborator, "North Central Cancer Treatment Group" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Adirondack Cancer Care - Glens Falls" are "Breast Cancer" (8 trials), "Lung Cancer" (6 trials), "Multiple Myeloma" (3 trials), "Pancreatic Cancer" (3 trials) and "Recurrent Breast Carcinoma" (3 trials). Many other conditions were trialed in "Adirondack Cancer Care - Glens Falls" in a lesser frequency.

Most popular intervention types in "Adirondack Cancer Care - Glens Falls" are "Drug" (38 trials), "Other" (14 trials), "Biological" (11 trials), "Procedure" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Letrozole" (4 trials), "cetuximab" (4 trials), "cyclophosphamide" (4 trials) and "paclitaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Adirondack Cancer Care - Glens Falls" are 33 trials for "All" genders and 11 trials for "Female" genders.

Currently, there are NaN active trials in "Adirondack Cancer Care - Glens Falls". undefined are not yet recruiting, 2 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Adirondack Cancer Care - Glens Falls, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Adirondack Cancer Care - Glens Falls, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".